Bologna, E.; Ditonno, F.; Licari, L.C.; Franco, A.; Manfredi, C.; Mossack, S.; Pandolfo, S.D.; De Nunzio, C.; Simone, G.; Leonardo, C.;
et al. Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX. Clin. Pract. 2024, 14, 508-520.
https://doi.org/10.3390/clinpract14020039
AMA Style
Bologna E, Ditonno F, Licari LC, Franco A, Manfredi C, Mossack S, Pandolfo SD, De Nunzio C, Simone G, Leonardo C,
et al. Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX. Clinics and Practice. 2024; 14(2):508-520.
https://doi.org/10.3390/clinpract14020039
Chicago/Turabian Style
Bologna, Eugenio, Francesco Ditonno, Leslie Claire Licari, Antonio Franco, Celeste Manfredi, Spencer Mossack, Savio Domenico Pandolfo, Cosimo De Nunzio, Giuseppe Simone, Costantino Leonardo,
and et al. 2024. "Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX" Clinics and Practice 14, no. 2: 508-520.
https://doi.org/10.3390/clinpract14020039
APA Style
Bologna, E., Ditonno, F., Licari, L. C., Franco, A., Manfredi, C., Mossack, S., Pandolfo, S. D., De Nunzio, C., Simone, G., Leonardo, C., & Franco, G.
(2024). Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX. Clinics and Practice, 14(2), 508-520.
https://doi.org/10.3390/clinpract14020039
